Anti-Tumor Potential of Mesenchymal Stem Cells (MSCs) Versus 5-Fluorouracil in HT-29 and HCT-116 Colorectal Cancer Cell Lines
Journal of Neuro and Oncology Research · 12.05.2026 · 6 (2) · 1-14
DOI: 10.46889/jnor.2026.6203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro and Oncology Research, online erschienen am 12.05.2026. Verfasst von Charbel Khalil und 11 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Despite the well-established association between Mesenchymal Stem Cells (MSCs) and tumor development, the lack of precise methods to distinguish between different MSC populations, along with their paradoxical roles in tumor progression and suppression, has hindered the advancement of MSC-based oncological therapies. In this study, we investigate the effects of human umbilical cord-derived MSCs (UC-MSCs) and their secretome, both alone and in comparison, with 5-Fluorouracil (5-FU), on the proliferation, migration capacity and tumor marker expression of Colorectal Cancer (CRC) cell lines. Chemotherapy regimens including 5-FU remain the gold standard for CRC treatment; however, their clinical efficacy is often limited by adverse side effects and the development of chemoresistance. In contrast, MSCs derived from Umbilical Cord (UC-MSCs), Bone Marrow (BM-MSCs) and Adipose Tissue (AT-MSCs), along with their bioactive secretome composed of immunomodulatory cytokines and chemokines, have demonstrated promising therapeutic potential in immune and inflammatory diseases in clinical trials. Owing to their natural tropism toward inflammatory signals, MSCs have also been explored as vehicles for targeted drug delivery to tumor sites. In this study, colorectal cancer tumor marker proteins were quantified using ELISA. The proliferative, apoptotic and anti-inflammatory effects of MSCs were assessed by Flow Cytometry (FCM), while Matrix Metalloproteinase (MMP) expression was analyzed using RT-PCR.
Zitieren
APA
Khalil, C., Gemayel, J., Salameh, R., Haddad, L., Ghanem, H., Moutran, D., Rustom, M., Hachem, G. E., Hanna, C., Ibrahim, A., Ghadieh, H. E., & Harb, F. (2026). Anti-Tumor Potential of Mesenchymal Stem Cells (MSCs) Versus 5-Fluorouracil in HT-29 and HCT-116 Colorectal Cancer Cell Lines. Journal of Neuro and Oncology Research, 6(2), 1-14. https://doi.org/10.46889/jnor.2026.6203
Vancouver
Khalil C, Gemayel J, Salameh R, Haddad L, Ghanem H, Moutran D, et al. Anti-Tumor Potential of Mesenchymal Stem Cells (MSCs) Versus 5-Fluorouracil in HT-29 and HCT-116 Colorectal Cancer Cell Lines. Journal of Neuro and Oncology Research. 2026;6(2):1-14. doi:10.46889/jnor.2026.6203
BibTeX
@article{Khalil2026,
author = {Khalil, Charbel and Gemayel, Jack and Salameh, Rawad and Haddad, Lara and Ghanem, Hady and Moutran, Dina and Rustom, Majd and Hachem, Georges El and Hanna, Colette and Ibrahim, Ahmad and Ghadieh, Hilda E and Harb, Frederic},
title = {Anti-Tumor Potential of Mesenchymal Stem Cells (MSCs) Versus 5-Fluorouracil in HT-29 and HCT-116 Colorectal Cancer Cell Lines},
journal = {Journal of Neuro and Oncology Research},
year = {2026},
volume = {6},
number = {2},
pages = {1--14},
doi = {10.46889/jnor.2026.6203}
}
EUVIMED